Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Organ On Chip Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4668734
    • |
  • 22 January, 2026
    • |
  • Global
    • |
  • 148 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Organ On Chip market size was valued at US$ 227 million in 2025 and is forecast to a readjusted size of US$ 1363 million by 2032 with a CAGR of 29.5% during review period.
A Organ on Chip is a small-scale device that replicates the mechanical and biological properties of human organs. These chips contain tiny channels lined with living human cells that form tissue layers. They can simulate the physiology of various organs, such as the heart, liver, lungs, kidneys, and intestines, allowing researchers to better understand organ-specific functions and diseases. These models are typically made using microfluidic technology, where human cells are cultured in a small, transparent chip, allowing researchers to simulate organ-specific functions and study disease processes, drug responses, and more. By offering more accurate, scalable, and human-relevant data, Human Organs-on-Chips are revolutionizing biomedical research and drug testing, providing a bridge between traditional animal models and human clinical trials.
The organ-on-a-chip market is primarily driven by the growing demand for more efficient, accurate, and ethically compliant in vitro biological models. Traditional drug development methods are often costly, time-consuming, and have low clinical translation success rates. In contrast, organ-on-a-chip technology, which closely mimics the microenvironment and functions of human organs, offers a promising alternative to improve drug screening efficiency and predictive accuracy. Increasing restrictions on animal testing, especially in regions like North America and Europe, are also accelerating the adoption of advanced alternatives that align with the "3Rs" principle—Replacement, Reduction, and Refinement—making organ-on-a-chip an ethically favorable solution. Furthermore, the rise of personalized and precision medicine is driving the use of patient-derived cells in organ chips for individualized drug testing and response prediction. Technological advancements across regenerative medicine, immunotherapy, and bioengineering are supporting the diversification and platformization of organ chip systems. In addition, sustained investment from both the public and private sectors in biotechnology is facilitating the commercialization of organ-on-a-chip platforms. As multi-organ chips evolve and integrate with AI, biosensors, and other digital health technologies, the market is expected to see rapid growth across high-value applications such as drug discovery, toxicity testing, and disease modeling.
Global main manufacturers of organ-on-chip include Emulate, Mimetas and TissUse, etc. The top three players hold a share about 40%. The global organ-on-chip is mainly produced in United States and Europe, they occupied for a share over 80%. North America is the largest market, has a share about 43%, followed by Europe and Japan, with share 37% and 8%, separately.
This report is a detailed and comprehensive analysis for global Organ On Chip market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Organ On Chip market size and forecasts, in consumption value ($ Million), 2021-2032
Global Organ On Chip market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Organ On Chip market size and forecasts, by Type and by End User, in consumption value ($ Million), 2021-2032
Global Organ On Chip market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Organ On Chip
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Organ On Chip market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Emulate, Mimetas, TissUse, Valo Health, CN Bio Innovations, Hesperos, Draper Laboratory, Nortis, Micronit Microtechnologies B.V., Kirkstall, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Organ On Chip market is split by Type and by End User. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by End User. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs
Market segment by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
Market segment by players, this report covers
Emulate
Mimetas
TissUse
Valo Health
CN Bio Innovations
Hesperos
Draper Laboratory
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Altis Biosystems
Bi/ond
Netri
Xona Microfluidics
SynVivo, Inc.
Beijing Daxiang Biotech
AVATARGET
Suzhou Jiyan Biopharmaceutical
InSphero
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Organ On Chip product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Organ On Chip, with revenue, gross margin, and global market share of Organ On Chip from 2021 to 2026.
Chapter 3, the Organ On Chip competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by End User, with consumption value and growth rate by Type, by End User, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Organ On Chip market forecast, by regions, by Type and by End User, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Organ On Chip.
Chapter 13, to describe Organ On Chip research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Organ On Chip by Type
    • 1.3.1 Overview: Global Organ On Chip Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Organ On Chip Consumption Value Market Share by Type in 2025
    • 1.3.3 Brain-on-a-chip
    • 1.3.4 Liver-on-a-chip
    • 1.3.5 Kidney-on-a-chip
    • 1.3.6 Lung-on-a-chip
    • 1.3.7 Heart-on-a-chip
    • 1.3.8 Intestine-on-a-chip
    • 1.3.9 Vessel-on-a-chip
    • 1.3.10 Other Organs
  • 1.4 Global Organ On Chip Market by End User
    • 1.4.1 Overview: Global Organ On Chip Market Size by End User: 2021 Versus 2025 Versus 2032
    • 1.4.2 Pharmaceutical & Biotechnology Companies
    • 1.4.3 Academic & Research Institutes
    • 1.4.4 Cosmetics Industry
    • 1.4.5 Others
  • 1.5 Global Organ On Chip Market Size & Forecast
  • 1.6 Global Organ On Chip Market Size and Forecast by Region
    • 1.6.1 Global Organ On Chip Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Organ On Chip Market Size by Region, (2021-2032)
    • 1.6.3 North America Organ On Chip Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Organ On Chip Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Organ On Chip Market Size and Prospect (2021-2032)
    • 1.6.6 South America Organ On Chip Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Organ On Chip Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Emulate
    • 2.1.1 Emulate Details
    • 2.1.2 Emulate Major Business
    • 2.1.3 Emulate Organ On Chip Product and Solutions
    • 2.1.4 Emulate Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Emulate Recent Developments and Future Plans
  • 2.2 Mimetas
    • 2.2.1 Mimetas Details
    • 2.2.2 Mimetas Major Business
    • 2.2.3 Mimetas Organ On Chip Product and Solutions
    • 2.2.4 Mimetas Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Mimetas Recent Developments and Future Plans
  • 2.3 TissUse
    • 2.3.1 TissUse Details
    • 2.3.2 TissUse Major Business
    • 2.3.3 TissUse Organ On Chip Product and Solutions
    • 2.3.4 TissUse Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 TissUse Recent Developments and Future Plans
  • 2.4 Valo Health
    • 2.4.1 Valo Health Details
    • 2.4.2 Valo Health Major Business
    • 2.4.3 Valo Health Organ On Chip Product and Solutions
    • 2.4.4 Valo Health Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Valo Health Recent Developments and Future Plans
  • 2.5 CN Bio Innovations
    • 2.5.1 CN Bio Innovations Details
    • 2.5.2 CN Bio Innovations Major Business
    • 2.5.3 CN Bio Innovations Organ On Chip Product and Solutions
    • 2.5.4 CN Bio Innovations Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 CN Bio Innovations Recent Developments and Future Plans
  • 2.6 Hesperos
    • 2.6.1 Hesperos Details
    • 2.6.2 Hesperos Major Business
    • 2.6.3 Hesperos Organ On Chip Product and Solutions
    • 2.6.4 Hesperos Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Hesperos Recent Developments and Future Plans
  • 2.7 Draper Laboratory
    • 2.7.1 Draper Laboratory Details
    • 2.7.2 Draper Laboratory Major Business
    • 2.7.3 Draper Laboratory Organ On Chip Product and Solutions
    • 2.7.4 Draper Laboratory Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Draper Laboratory Recent Developments and Future Plans
  • 2.8 Nortis
    • 2.8.1 Nortis Details
    • 2.8.2 Nortis Major Business
    • 2.8.3 Nortis Organ On Chip Product and Solutions
    • 2.8.4 Nortis Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Nortis Recent Developments and Future Plans
  • 2.9 Micronit Microtechnologies B.V.
    • 2.9.1 Micronit Microtechnologies B.V. Details
    • 2.9.2 Micronit Microtechnologies B.V. Major Business
    • 2.9.3 Micronit Microtechnologies B.V. Organ On Chip Product and Solutions
    • 2.9.4 Micronit Microtechnologies B.V. Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Micronit Microtechnologies B.V. Recent Developments and Future Plans
  • 2.10 Kirkstall
    • 2.10.1 Kirkstall Details
    • 2.10.2 Kirkstall Major Business
    • 2.10.3 Kirkstall Organ On Chip Product and Solutions
    • 2.10.4 Kirkstall Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Kirkstall Recent Developments and Future Plans
  • 2.11 Cherry Biotech SAS
    • 2.11.1 Cherry Biotech SAS Details
    • 2.11.2 Cherry Biotech SAS Major Business
    • 2.11.3 Cherry Biotech SAS Organ On Chip Product and Solutions
    • 2.11.4 Cherry Biotech SAS Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Cherry Biotech SAS Recent Developments and Future Plans
  • 2.12 Else Kooi Laboratory
    • 2.12.1 Else Kooi Laboratory Details
    • 2.12.2 Else Kooi Laboratory Major Business
    • 2.12.3 Else Kooi Laboratory Organ On Chip Product and Solutions
    • 2.12.4 Else Kooi Laboratory Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Else Kooi Laboratory Recent Developments and Future Plans
  • 2.13 Altis Biosystems
    • 2.13.1 Altis Biosystems Details
    • 2.13.2 Altis Biosystems Major Business
    • 2.13.3 Altis Biosystems Organ On Chip Product and Solutions
    • 2.13.4 Altis Biosystems Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Altis Biosystems Recent Developments and Future Plans
  • 2.14 Bi/ond
    • 2.14.1 Bi/ond Details
    • 2.14.2 Bi/ond Major Business
    • 2.14.3 Bi/ond Organ On Chip Product and Solutions
    • 2.14.4 Bi/ond Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Bi/ond Recent Developments and Future Plans
  • 2.15 Netri
    • 2.15.1 Netri Details
    • 2.15.2 Netri Major Business
    • 2.15.3 Netri Organ On Chip Product and Solutions
    • 2.15.4 Netri Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Netri Recent Developments and Future Plans
  • 2.16 Xona Microfluidics
    • 2.16.1 Xona Microfluidics Details
    • 2.16.2 Xona Microfluidics Major Business
    • 2.16.3 Xona Microfluidics Organ On Chip Product and Solutions
    • 2.16.4 Xona Microfluidics Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Xona Microfluidics Recent Developments and Future Plans
  • 2.17 SynVivo, Inc.
    • 2.17.1 SynVivo, Inc. Details
    • 2.17.2 SynVivo, Inc. Major Business
    • 2.17.3 SynVivo, Inc. Organ On Chip Product and Solutions
    • 2.17.4 SynVivo, Inc. Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 SynVivo, Inc. Recent Developments and Future Plans
  • 2.18 Beijing Daxiang Biotech
    • 2.18.1 Beijing Daxiang Biotech Details
    • 2.18.2 Beijing Daxiang Biotech Major Business
    • 2.18.3 Beijing Daxiang Biotech Organ On Chip Product and Solutions
    • 2.18.4 Beijing Daxiang Biotech Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Beijing Daxiang Biotech Recent Developments and Future Plans
  • 2.19 AVATARGET
    • 2.19.1 AVATARGET Details
    • 2.19.2 AVATARGET Major Business
    • 2.19.3 AVATARGET Organ On Chip Product and Solutions
    • 2.19.4 AVATARGET Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 AVATARGET Recent Developments and Future Plans
  • 2.20 Suzhou Jiyan Biopharmaceutical
    • 2.20.1 Suzhou Jiyan Biopharmaceutical Details
    • 2.20.2 Suzhou Jiyan Biopharmaceutical Major Business
    • 2.20.3 Suzhou Jiyan Biopharmaceutical Organ On Chip Product and Solutions
    • 2.20.4 Suzhou Jiyan Biopharmaceutical Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Suzhou Jiyan Biopharmaceutical Recent Developments and Future Plans
  • 2.21 InSphero
    • 2.21.1 InSphero Details
    • 2.21.2 InSphero Major Business
    • 2.21.3 InSphero Organ On Chip Product and Solutions
    • 2.21.4 InSphero Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
    • 2.21.5 InSphero Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Organ On Chip Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Organ On Chip by Company Revenue
    • 3.2.2 Top 3 Organ On Chip Players Market Share in 2025
    • 3.2.3 Top 6 Organ On Chip Players Market Share in 2025
  • 3.3 Organ On Chip Market: Overall Company Footprint Analysis
    • 3.3.1 Organ On Chip Market: Region Footprint
    • 3.3.2 Organ On Chip Market: Company Product Type Footprint
    • 3.3.3 Organ On Chip Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Organ On Chip Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Organ On Chip Market Forecast by Type (2027-2032)

5 Market Size Segment by End User

  • 5.1 Global Organ On Chip Consumption Value Market Share by End User (2021-2026)
  • 5.2 Global Organ On Chip Market Forecast by End User (2027-2032)

6 North America

  • 6.1 North America Organ On Chip Consumption Value by Type (2021-2032)
  • 6.2 North America Organ On Chip Market Size by End User (2021-2032)
  • 6.3 North America Organ On Chip Market Size by Country
    • 6.3.1 North America Organ On Chip Consumption Value by Country (2021-2032)
    • 6.3.2 United States Organ On Chip Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Organ On Chip Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Organ On Chip Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Organ On Chip Consumption Value by Type (2021-2032)
  • 7.2 Europe Organ On Chip Consumption Value by End User (2021-2032)
  • 7.3 Europe Organ On Chip Market Size by Country
    • 7.3.1 Europe Organ On Chip Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Organ On Chip Market Size and Forecast (2021-2032)
    • 7.3.3 France Organ On Chip Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Organ On Chip Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Organ On Chip Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Organ On Chip Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Organ On Chip Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Organ On Chip Consumption Value by End User (2021-2032)
  • 8.3 Asia-Pacific Organ On Chip Market Size by Region
    • 8.3.1 Asia-Pacific Organ On Chip Consumption Value by Region (2021-2032)
    • 8.3.2 China Organ On Chip Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Organ On Chip Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Organ On Chip Market Size and Forecast (2021-2032)
    • 8.3.5 India Organ On Chip Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Organ On Chip Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Organ On Chip Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Organ On Chip Consumption Value by Type (2021-2032)
  • 9.2 South America Organ On Chip Consumption Value by End User (2021-2032)
  • 9.3 South America Organ On Chip Market Size by Country
    • 9.3.1 South America Organ On Chip Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Organ On Chip Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Organ On Chip Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Organ On Chip Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Organ On Chip Consumption Value by End User (2021-2032)
  • 10.3 Middle East & Africa Organ On Chip Market Size by Country
    • 10.3.1 Middle East & Africa Organ On Chip Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Organ On Chip Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Organ On Chip Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Organ On Chip Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Organ On Chip Market Drivers
  • 11.2 Organ On Chip Market Restraints
  • 11.3 Organ On Chip Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Organ On Chip Industry Chain
  • 12.2 Organ On Chip Upstream Analysis
  • 12.3 Organ On Chip Midstream Analysis
  • 12.4 Organ On Chip Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Organ On Chip. Industry analysis & Market Report on Organ On Chip is a syndicated market report, published as Global Organ On Chip Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Organ On Chip market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo